As of 2019, the European Association of Urology (EAU) guidelines recommend mpMRI to be used before prostate biopsy in patients with suspicion of PCA based on elevated prostate-specific antigen (PSA) or a suspicious digital rectal examination (DRE) [4]. This evidence concerns the gene KLK3 and posterior cortical atrophy.